A73671-100
|
Epigentek Group Inc
|
SARS-CoV-2 N Recombinant Antibody
|
SARS-CoV-2
|
ELISA, GICA; Recommended dilution: ELISA 1:10000-1:50000, GICA 1:500-1:20000
|
|
A73672-100
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody
|
SARS-CoV-2
|
ELISA, GICA, Neutralization; Recommended dilution: ELISA 1:10000-1:50000, GICA 1:500-1:40000, Neutralization 1:100-1:10000
|
|
A73673-050
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody, HRP Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73673-100
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody, HRP Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73674-050
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody, FITC Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73674-100
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody, FITC Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73675-050
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody, Biotin Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73675-100
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody, Biotin Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73676-100
|
Epigentek Group Inc
|
SARS-CoV-2 N Recombinant Antibody
|
SARS-CoV-2
|
ELISA, WB, GICA; Recommended dilution: ELISA 1:10000-1:50000, WB 1:500-1:5000, GICA 1:1000-1:50000
|
|
A73677-050
|
Epigentek Group Inc
|
SARS-CoV-2 N Recombinant Antibody, HRP Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73677-100
|
Epigentek Group Inc
|
SARS-CoV-2 N Recombinant Antibody, HRP Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73678-050
|
Epigentek Group Inc
|
SARS-CoV-2 N Recombinant Antibody, FITC Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73678-100
|
Epigentek Group Inc
|
SARS-CoV-2 N Recombinant Antibody, FITC Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73679-050
|
Epigentek Group Inc
|
SARS-CoV-2 N Recombinant Antibody, Biotin Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73679-100
|
Epigentek Group Inc
|
SARS-CoV-2 N Recombinant Antibody, Biotin Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
A73683-100
|
Epigentek Group Inc
|
SARS-COV-2 Neutralizing Monoclonal Antibody [DA0002]
|
SARS-CoV-2
|
ELISA
|
|
TA160051
|
OriGene Technologies
|
SARS-CoV-2/SARS-CoV Spike Protein, Rabbit Polyclonal Antibody
|
SARS-CoV-2, SARS-CoV
|
ELISA, WB
|
|
TA160070
|
OriGene Technologies
|
SARS-CoV-2 Spike Protein, Rabbit Polyclonal Antibody
|
SARS-CoV-2, SARS-CoV
|
ELISA, WB
|
|
TA190323
|
OriGene Technologies
|
SARS-CoV-2 N Protein Human Monoclonal Antibody
|
SARS-CoV-2
|
ELISA, ICC, WB
|
|
TA190324
|
OriGene Technologies
|
SARS-CoV-2 N Protein Human Monoclonal Antibody
|
SARS-CoV-2
|
ELISA, WB
|
|
TA190325
|
OriGene Technologies
|
SARS-CoV-2 Spike Protein RBD Monoclonal Antibody
|
SARS-CoV-2
|
ELISA
|
|
TA355145
|
OriGene Technologies
|
SARS Spike protein antibody, Rabbit Polyclonal Antibody
|
SARS-CoV-2
|
ELISA
|
|
TA355203
|
OriGene Technologies
|
S Protein Human Monoclonal Antibody
|
SARS-CoV-2
|
ELISA, FC
|
|
TA355205
|
OriGene Technologies
|
S Protein Human Monoclonal Antibody
|
SARS-CoV-2
|
ELISA, FC
|
|
TA890226
|
OriGene Technologies
|
SARS-CoV-2 N Protein, Rabbit Polyclonal Antibody
|
SARS-CoV-2
|
ELISA, ICC, IHC, WB
|
|